BOSTON SCIENTIFIC CORPORATION Letters of Credit Outstanding, Amount
BOSTON SCIENTIFIC CORPORATION (BSX) had Letters of Credit Outstanding, Amount of $189.00 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Other Liabilities and Financial Instruments Subject to Mandatory Redemption
us-gaap:LettersOfCreditOutstandingAmount · last filed 2026-08-03
- 2026-06-30: Letters of Credit Outstanding, Amount $189.00M.
- 2026-03-31: Letters of Credit Outstanding, Amount $193.00M.
- 2025-12-31: Letters of Credit Outstanding, Amount $203.00M.
- 2025-09-30: Letters of Credit Outstanding, Amount $223.00M.
| Period end | Letters of Credit Outstanding, Amount |
|---|---|
| 2026-06-30 | $189.00M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $193.00M 10-Q · filed 2026-05-01 |
| 2025-12-31 | $203.00M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $223.00M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $220.00M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $218.00M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $206.00M 10-K · filed 2026-02-17 |
| 2024-09-30 | $216.00M 10-Q · filed 2024-11-01 |
| 2024-06-30 | $189.00M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $174.00M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $174.00M 10-K · filed 2025-02-18 |
| 2023-09-30 | $151.00M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $148.00M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $143.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $135.00M 10-K · filed 2024-02-20 |
| 2022-09-30 | $120.00M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $128.00M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $132.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $134.00M 10-K · filed 2023-02-23 |
| 2021-09-30 | $135.00M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $135.00M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $126.00M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $124.00M 10-K · filed 2022-02-23 |
| 2020-09-30 | $125.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $111.00M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $107.00M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $105.00M 10-K · filed 2021-02-23 |
| 2018-12-31 | $111.00M 10-K · filed 2020-02-25 |
| 2017-12-31 | $49.00M 10-K · filed 2018-02-20 |
| 2017-09-30 | $37.00M 10-Q · filed 2017-11-02 |
| 2017-03-31 | $44.00M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $44.00M 10-K · filed 2018-02-20 |
| 2016-09-30 | $39.00M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $43.00M 10-Q · filed 2016-08-03 |
| 2016-03-31 | $43.00M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $44.00M 10-K · filed 2017-02-23 |
| 2015-09-30 | $65.00M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $58.00M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $58.00M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $59.00M 10-K · filed 2016-02-24 |
| 2014-09-30 | $78.00M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $78.00M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $78.00M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $78.00M 10-K · filed 2015-02-25 |
| 2013-09-30 | $74.00M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $93.00M 10-Q · filed 2013-08-07 |
| 2013-03-31 | $93.00M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $94.00M 10-K · filed 2014-02-26 |
| 2011-12-31 | $128.00M 8-K · filed 2013-05-29 |
| 2010-12-31 | $120.00M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |